FDA pauses Watertown biotech ’s schizophrenia trial

The U.S. Food and Drug Administration placed a clinical hold on a Watertown biotech ’s schizophrenia drug trial after new pre-clinical data showed convulsions in rabbits.

https://www.bizjournals.com/boston/news/2024/04/15/fda-pauses-watertown-biotech-...

Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news

More News: Biotechnology | Food and Drug Administration (FDA) | Health Management | Pharmaceuticals | Schizophrenia